Ploussard G - Search Results

1

Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Ploussard G, et al. World J Urol. 2020 Mar;38(3):663-671. doi: 10.1007/s00345-019-02848-x. Epub 2019 Jun 13. World J Urol. 2020. PMID: 31197523

2

High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance.

Ploussard G, Plennevaux G, Allory Y, Salomon L, Azoulay S, Vordos D, Hoznek A, Abbou CC, de la Taille A. Ploussard G, et al. World J Urol. 2009 Oct;27(5):587-92. doi: 10.1007/s00345-009-0413-1. Epub 2009 Apr 17. World J Urol. 2009. PMID: 19373471 Free PMC article.

3

Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.

Ploussard G, Dubosq F, Boublil V, Allory Y, de la Taille A, Vordos D, Hoznek A, Abbou CC, Salomon L. Ploussard G, et al. J Urol. 2009 Oct;182(4):1342-9. doi: 10.1016/j.juro.2009.06.050. Epub 2009 Aug 14. J Urol. 2009. PMID: 19683310

4

The role of biopsy core number in selecting prostate cancer patients for active surveillance.

Ploussard G, Xylinas E, Salomon L, Allory Y, Vordos D, Hoznek A, Abbou CC, de la Taille A. Ploussard G, et al. Eur Urol. 2009 Dec;56(6):891-8. doi: 10.1016/j.eururo.2009.07.053. Epub 2009 Aug 12. Eur Urol. 2009. PMID: 19683860

5

Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?

Ploussard G, Salomon L, Xylinas E, Allory Y, Vordos D, Hoznek A, Abbou CC, de la Taille A. Ploussard G, et al. J Urol. 2010 Feb;183(2):539-44. doi: 10.1016/j.juro.2009.10.009. Epub 2009 Dec 14. J Urol. 2010. PMID: 20006888 Free article.

6

Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors.

Alenda O, Ploussard G, Mouracade P, Xylinas E, de la Taille A, Allory Y, Vordos D, Hoznek A, Abbou CC, Salomon L. Alenda O, et al. Among authors: ploussard g. World J Urol. 2011 Oct;29(5):671-6. doi: 10.1007/s00345-010-0620-9. Epub 2010 Nov 24. World J Urol. 2011. PMID: 21107843

7

Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance.

Ploussard G, Durand X, Xylinas E, Moutereau S, Radulescu C, Forgue A, Nicolaiew N, Terry S, Allory Y, Loric S, Salomon L, Vacherot F, de la Taille A. Ploussard G, et al. Eur Urol. 2011 Mar;59(3):422-9. doi: 10.1016/j.eururo.2010.11.044. Epub 2010 Dec 8. Eur Urol. 2011. PMID: 21156337

8

Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme.

Ploussard G, Xylinas E, Durand X, Ouzaïd I, Allory Y, Bouanane M, Abbou CC, Salomon L, de la Taille A. Ploussard G, et al. BJU Int. 2011 Aug;108(4):513-7. doi: 10.1111/j.1464-410X.2010.09974.x. Epub 2010 Dec 22. BJU Int. 2011. PMID: 21176083

9

The contemporary concept of significant versus insignificant prostate cancer.

Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm MO, Bjartell AS, Montorsi F, Freedland SJ, Erbersdobler A, van der Kwast TH. Ploussard G, et al. Eur Urol. 2011 Aug;60(2):291-303. doi: 10.1016/j.eururo.2011.05.006. Epub 2011 May 17. Eur Urol. 2011. PMID: 21601982 Review.

10

Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification.

Ploussard G, Masson-Lecomte A, Beauval JB, Ouzzane A, Bonniol R, Buge F, Fadli S, Rouprêt M, Rebillard X, Gaschignard N, Pfister C, Villers A, Soulié M, Salomon L; Prostate Cancer Committee of the French Association of Urology. Ploussard G, et al. Urology. 2011 Sep;78(3):607-13. doi: 10.1016/j.urology.2011.05.021. Epub 2011 Jul 23. Urology. 2011. PMID: 21783233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters